Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Adjaye, James  [Clear All Filters]
Journal Article
Graffmann N, Brands J, Görgens A, Castro SVitoriano, Santourlidis S, Reckert A, Michele I, Ritz-Timme S, Fischer JChristian, Adjaye J, et al. Age-related increase of EED expression in early hematopoietic progenitor cells is associated with global increase of the histone modification H3K27me3. Stem Cells Dev. 2015.
Graffmann N, Ncube A, Wruck W, Adjaye J. Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density. PLoS One. 2018;13(7):e0200416.
Nimtz L, Hartmann J, Tigges J, Masjosthusmann S, Schmuck M, Keßel E, Theiss S, Köhrer K, Petzsch P, Adjaye J, et al. Characterization and application of electrically active neuronal networks established from human induced pluripotent stem cell-derived neural progenitor cells for neurotoxicity evaluation. Stem Cell Res. 2020;45:101761.
Erichsen L, Adjaye J. Crosstalk between age accumulated DNA-damage and the SIRT1-AKT-GSK3ß axis in urine derived renal progenitor cells. Aging (Albany NY). 2022;14(undefined).
Hossini AM, Megges M, Prigione A, Lichtner B, Toliat MR, Wruck W, Schröter F, Nuernberg P, Kroll H, Makrantonaki E, et al. Erratum: Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics. 2015;16(1):433.
Graffmann N, Bohndorf M, Ncube A, Kawala M-A, Wruck W, Kashofer K, Zatloukal K, Adjaye J. Establishment and characterization of an iPSC line from a 35 years old high grade patient with nonalcoholic fatty liver disease (30-40% steatosis) with homozygous wildtype PNPLA3 genotype. Stem Cell Res. 2018;31:113-116.
Graffmann N, Bohndorf M, Ncube A, Wruck W, Kashofer K, Zatloukal K, Adjaye J. Establishment and characterization of an iPSC line from a 58 years old high grade patient with nonalcoholic fatty liver disease (70% steatosis) with homozygous wildtype PNPLA3 genotype. Stem Cell Res. 2018;31:131-134.
Martins S, Bohndorf M, Graffmann N, Wruck W, Chrzanowska KH, Adjaye J. Fibroblast-derived integration-free iPSC line ISRM-NBS1 from an 18-year-old Nijmegen Breakage Syndrome patient carrying the homozygous NBN c.657_661del5 mutation. Stem Cell Res. 2018;34:101372.
Loerch C, Szepanowski L-P, Reiss J, Adjaye J, Graffmann N. Forskolin induces FXR expression and enhances maturation of iPSC-derived hepatocyte-like cells. Front Cell Dev Biol. 2024;12:1383928.
Royer-Pokora B, Wruck W, Adjaye J, Beier M. Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin. PLoS One. 2023;18(1):e0270380.
Graffmann N, Martins S, Ljubikj T, Matte JCarole, Bohndorf M, Wruck W, Adjaye J. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A). Stem Cell Res. 2021;51:102167.
Cheng X, Dimou E, Alborzinia H, Wenke F, Goehring A, Reuter S, Mah N, Fuchs HRalph, Andrade-Navarro MA, Adjaye J, et al. Identification of 2-[4-[(4-methoxyphenyl)methoxy]-phenyl]acetonitrile and derivatives as potent Oct3/4 inducers. J Med Chem. 2015.
Dabiri Y, Gama-Brambila RA, Taškova K, Herold K, Reuter S, Adjaye J, Utikal J, Mrowka R, Wang J, Andrade-Navarro MA, et al. Imidazopyridines as Potent KDM5 Demethylase Inhibitors Promoting Reprogramming Efficiency of Human iPSCs. iScience. 2019;12:168-181.
Graffmann N, Scherer B, Adjaye J. In vitro differentiation of pluripotent stem cells into hepatocyte like cells - Basic principles and current progress. Stem Cell Res. 2022;61:102763.
Nguyen L, Thewes L, Westerhoff M, Wruck W, Reichert AS, Berndt C, Adjaye J. JNK Signalling Regulates Self-Renewal of Proliferative Urine-Derived Renal Progenitor Cells via Inhibition of Ferroptosis. Cells. 2023;12(17).
Martins S, Yigit H, Bohndorf M, Graffmann N, Fiszl ARobert, Wruck W, Sleegers K, Van Broeckhoven C, Adjaye J. Lymphoblast-derived integration-free iPSC line AD-TREM2-3 from a 74 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant. Stem Cell Res. 2018;30:141-144.
Wruck W, Schröter F, Adjaye J. Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsiesand iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Revealsan Association with FOXA1 and FOXA2 Gene Regulatory Networks. J Alzheimers Dis. 2016.
Fuchs H, Theuser M, Wruck W, Adjaye J. miR-27 Negatively Regulates Pluripotency-Associated Genes in Human Embryonal Carcinoma Cells. PLoS One. 2014;9(11):e111637.
Prigione A, Adjaye J. A mitochondrial strategy for safeguarding the reprogrammed genome. Cell Regen (Lond). 2014;3(1):5.
Graffmann N, Ring S, Kawala M-A, Wruck W, Ncube A, Trompeter H-I, Adjaye J. Modelling NAFLD with human pluripotent stem cell derived immature hepatocyte like cells reveals activation of PLIN2 and confirms regulatory functions of PPARα. Stem Cells Dev. 2016.
Schröter F, Adjaye J. The proteasome complex and the maintenance of pluripotency: sustain the fate by mopping up?. Stem Cell Res Ther. 2014;5(1):24.
Peterson H, Dawud RAbu, Garg A, Wang Y, Vilo J, Xenarios I, Adjaye J. Qualitative modeling identifies IL-11 as a novel regulator in maintaining self-renewal in human pluripotent stem cells. Front Physiol. 2013;4:303.
Devika AS, Wruck W, Adjaye J, Sudheer S. The quest for pluripotency: a comparative analysis across mammalian species. Reproduction. 2019.
Spitzhorn L-S, Kordes C, Megges M, Sawitza I, Götze S, Reichert D, Schulze-Matz P, Graffmann N, Bohndorf M, Wruck W, et al. Transplanted human pluripotent stem cell-derived mesenchymal stem cells support liver regeneration in Gunn rats. Stem Cells Dev. 2018.